Recognition Awards

Click here to Make a Nomination

The Recognition Award program has been established by the Association as a means of recognizing the commitment, achievement and/or potential of individuals in the field of Clinical Mass Spectrometry. This program is one of the means by which the Association encourages the advancement of mass spectrometry in clinical chemistry via the promotion of research, education and application.

The MSACL Distinguished Contribution Award

In Recognition of Achievements Made in the Field of Clinical Mass Spectrometry that have Furthered the Advancement of Knowledge and the Implementation of Science for the Benefit of Humanity © MSACL

Representative Award Medal

Composition: 0.925 silver

Make a Nomination here

Self-nominations are not recognized for consideration.

The purpose of the Distinguished Contribution Award is to recognize a contributor who has conducted research, teaching or application of Mass Spectrometry in Clinical Chemistry of significant impact.

Nominations will be evaluated on elements of the following criteria:

1. Program of research: Quality, scope and overall impact on the profession,
2. The extent to which the contribution is based on original concepts and/or innovative practices recognized throughout the field over a sustained period,
3. The impact the contribution has had on the field, including education, influence on practitioners and the care of patients, organizations, thought leaders, and research, and
4. Influence on research advancement and career development within the profession

Nomination Application Information should include:

1. The basic contact info of the nominee.
2. A concise summary of the applicant's accomplishments and/or contributions.
3. The basic contact info of the nominator.

The Award recognizes a focused or singular achievement in education, technology development or applied mass spectrometry in clinical chemistry. The award will be conferred at the MSACL US Annual Conference.

PREVIOUS AWARDEES 2015 US: David Millington Tandem Mass Spectrometry in Clinical Diagnostics, Newborn Screening and Targeted Metabolomics 2015 EU: Linda Thienpont Mass Spectrometry as Metrological Anchor in Laboratory Medicine – a Meandering River 2016 US: Kenneth Setchell What We Can Learn from a Drop of Urine – Metabolomics at It's Earliest: Discoveries of Bile Acid Synthesis Disorders, a New Category of Fatal Metabolic Liver Disease and Development of a Treatment 2017 US: Catherine Feneslau Rapid Characterization of Microorganisms by Mass Spectrometry: What can be Learned and How? 2017 EU: Isabelle Fournier Laser-based Mass Spectrometry in Clinics: Changing the Paradigm of Molecular Diagnosis 2018 US: Richard Yost The Triple Quadrupole: Innovation, Serendipity and Persistence 2018 EU: Cedric Shackleton Mass Spectrometry and the Elucidation of Steroid Metabolome 2019 US: Donald Hunt Immunotherapy of Cancer and the Role of Mass Spectrometry; An Overview and New Results

Deadline:

The MSACL 2020 US application deadline is September 1, 2019.

Selection Procedure:

Nominators and award winner will receive notification by September 14, 2019. The award winner will be honored during the MSACL 2020 US Conference in Palm Springs, CA.